Apixaban to Prevent Covert Infarcts after Cryptogenic Stroke in Patients with Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial

NCS News

Apixaban to Prevent Covert Infarcts after Cryptogenic Stroke in Patients with Atrial Cardiopathy: A Secondary Analysis of the ARCADIA Randomized Clinical Trial

Written By: William Spears, MD

Background: The recently published ARCADIA trial, which enrolled patients with ESUS and signs of atrial cardiopathy, failed to show that treatment with anticoagulation prevented recurrent ischemic stroke.

Neurocritical care society

Neurocritical Care Insights And
Perspectives From Around the World

Join Our Mailing List

Leading Insights, International

Artificial Intelligence in Neurocritical Care: Perspectives from National Representatives of the NCS Asia Oceania Chapter

Written By: Gentle S Shrestha, MD, FNCS; Andrew Udy, PhD, FCICM; Girija P Rath, MD, DM; Masao Nagayama, MD, PhD; Prashant Kumar, MD, MBA, FICCM; Saurabh Anand, MBBS, MD; et al.

The field of artificial intelligence (AI) and machine learning (ML) has rapidly emerged as a force in clinical medicine and is expected to continue evolving in the future.

NCS News, NCSTJC

Changing Names: The #NCSTJC is now the Neurocritical Care Society Virtual Journal Club (#NCSVJC)

Written By: Eric Lawson, MD

To more accurately reflect the #NCSTJC expansion into other social media platforms, such as LinkedIn and Bluesky, we have updated the name to the Neurocritical Care Society Virtual Journal Club (#NCSVJC). Please join us monthly on X for the discussions with expansion to other social media...

Stories of Hope

Glen’s Story of Hope

Written By: Liz Jelnicky, ACNP-BC ; Tommy Thomas, MD, PhD; Lauren Koffman, DO, MS